Skip to main content

Advertisement

Log in

The Severity of Dextran Sodium Sulfate-Induced Colitis Can Differ Between Dextran Sodium Sulfate Preparations of the Same Molecular Weight Range

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

We hypothesized that the severity of dextran sodium sulfate (DSS)-induced colitis could differ between DSS preparations of the same molecular weight, and that this difference may be affected by the sulfur content. To test this, we used three DSS preparations of similar molecular weights but with different sulfur contents.

Methods

Three DSS preparations with molecular weights of 40,000 to 50,000 were tested: MP Biomedicals (MP Bio), USB (USB), and The Lab Depot (The Lab). Epithelial cell lines were used to assess the levels of poly (ADP-ribose) polymerase (PARP) in the presence of 2.0% DSS in vitro. Eight-week-old female C57/B6 mice were fed 2.0% DSS in water for 1 week, and then sacrificed to investigate the effects of the DSS preparations in vivo.

Results

In vitro experiments using CaCo-2 and CMT-93 cells revealed decreased PARP levels from all DSS preparations. Notably, the PARP level was significantly decreased in CaCo-2 cells treated with DSS from USB as compared to The Lab Mice treated with The Lab DSS had significantly decreased body weight losses on day 7 as compared to mice receiving DSS from MP Bio and USB. This result was supported by their DAI score, colon weight/length ratio, and histological scores.

Conclusion

The severity of colitis can differ between similar DSS preparations of the same molecular weight range. This difference in colitogenic properties may be affected by the total sulfur content of each DSS preparation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Marcus R, Watt J. Seaweeds and ulcerative colitis in laboratory animals. Lancet. 1969;2:489–490.

    Article  PubMed  CAS  Google Scholar 

  2. Watt J, Marcus R. Ulceration of the colon in rabbits fed sulphated amylopectin. J Pharm Pharmacol. 1972;24:68–69.

    Article  PubMed  CAS  Google Scholar 

  3. Marcus R, Watt J. Ulcerative disease of the colon in laboratory animals induced by pepsin inhibitors. Gastroenterology. 1974;67:473–483.

    PubMed  CAS  Google Scholar 

  4. Marcus R, Watt J. Colonic ulceration in guinea-pigs and rabbits fed lignosulphonate. Vet Rec. 1974;94:580.

    Article  PubMed  CAS  Google Scholar 

  5. Watt J, Marcus R. Proceedings: effect of lignosulphonate on the colon of guinea-pigs. Proc Nutr Soc. 1974;33:65A–66A.

    PubMed  CAS  Google Scholar 

  6. Anderson W, Watt J. Inhibition of peptic activity, protection against histamine ulceration in the guinea pig, and combination with gastric mucin by an algal polyanion. J Pharm Pharmacol. 1959;11:318.

    Article  PubMed  CAS  Google Scholar 

  7. Barnes WA, Redo SF, Ecker RR, Wenig J. Dextran sulfate. A new and potent antiulcer agent. Am J Surg. 1967;113:27–31.

    Article  PubMed  CAS  Google Scholar 

  8. Vocac JA, Alphin RS. Effects and mechanism of action of a lignosulphonate on experimental gastric ulceration in rats. Eur J Pharmacol. 1968;4:99–102.

    Article  PubMed  CAS  Google Scholar 

  9. Rosen H, Townsend P, Seifter J. Effect of sodium polyanhydromannuronic acid sulfate on incidence of ulcers in the Shay rat. Proc Soc Exp Biol Med. 1956;92:439–440.

    PubMed  CAS  Google Scholar 

  10. Bianchi RG, Cook DL. Antipeptic and antiulcerogenic properties of a synthetic sulfated polysaccharide (Sn-263). Gastroenterology. 1964;47:409–414.

    PubMed  CAS  Google Scholar 

  11. Ohkusa T. Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora. Nihon Shokakibyo Gakkai Zasshi. 1985;82:1327–1336.

    PubMed  CAS  Google Scholar 

  12. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol. 2005;288:G1328–G1338.

    CAS  Google Scholar 

  13. Hahm KB, Im YH, Parks TW, et al. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut. 2001;49:190–198.

    Article  PubMed  CAS  Google Scholar 

  14. Araki Y, Mukaisho K, Sugihara H, Fujiyama Y, Hattori T. Proteus mirabilis sp. intestinal microflora grow in a dextran sulfate sodium-rich environment. Int J Mol Med. 2010;25:203–208.

    PubMed  CAS  Google Scholar 

  15. Watt J, Marcus R. Experimental ulcerative disease of the colon in animals. Gut. 1973;14:506–510.

    Article  PubMed  CAS  Google Scholar 

  16. Araki Y, Mukaisyo K, Sugihara H, Fujiyama Y, Hattori T. Increased apoptosis and decreased proliferation of colonic epithelium in dextran sulfate sodium-induced colitis in mice. Oncol Rep. 2010;24:869–874.

    Article  PubMed  CAS  Google Scholar 

  17. Araki Y, Andoh A, Fujiyama Y, et al. Application of 2-aminopyridine fluorescence labeling in the analysis of in vivo and in vitro metabolism of dextran sulfate sodium by size-exclusion high-performance liquid chromatography. J Chromatogr. 2001;753:209–215.

    Article  CAS  Google Scholar 

  18. Araki Y, Katoh T, Urabe M, Kishi Y, Ishizuka I, Fujiyama Y. The analysis of pyridylamino-dextran sulfate oligomers by high-performance liquid chromatography and a novel detection system for sulfated polysaccharides. Oncol Rep. 2004;12:363–367.

    PubMed  CAS  Google Scholar 

  19. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–249.

    PubMed  CAS  Google Scholar 

  20. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 1994;107:1643–1652.

    PubMed  CAS  Google Scholar 

  21. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702.

    PubMed  CAS  Google Scholar 

  22. Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev. 1996;15:177–186.

    Article  PubMed  CAS  Google Scholar 

  23. Ohkusa T, Okayasu I, Tokoi S, Araki A, Ozaki Y. Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion. 1995;56:159–164.

    Article  PubMed  CAS  Google Scholar 

  24. Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res. 1996;45:181–191.

    Article  PubMed  CAS  Google Scholar 

  25. Yu SW, Wang H, Poitras MF, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 2002;297:259–263.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeki Bamba.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bamba, S., Andoh, A., Ban, H. et al. The Severity of Dextran Sodium Sulfate-Induced Colitis Can Differ Between Dextran Sodium Sulfate Preparations of the Same Molecular Weight Range. Dig Dis Sci 57, 327–334 (2012). https://doi.org/10.1007/s10620-011-1881-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-011-1881-x

Keywords

Navigation